Figure 3 shows the prediction-corrected VPC plots, where most observed data fell within the 95% confidence interval (CI) generated by model simulations, showing that the final model had good forecasting ability
GLP-1 Diabetes Medications Linked to Lower Epilepsy Risk The reduced epilepsy risk was seen within one year of treatment and persisted over time, especially with semaglutide
Side Effects Both medications share similar side effect profiles: Nausea (usually mild and temporary) Diarrhea or constipation Decreased appetite Fatigue during initial weeks Tirzepatide may cause slightly more gastrointestinal effects initially due to its dual-action mechanism, but most patients adapt within 2-4 weeks
Patients typically feel relaxed while receiving the infusion, though some may notice mild warmth or pressure in the chest or stomach
Women who are pregnant or lactating mothers should be careful regarding these injections
Scientific studies suggest that GLP-1 may affect appetite regulation and insulin secretion, making it a point of interest for individuals seeking to manage particular health conditions effectively